scholarly article | Q13442814 |
P356 | DOI | 10.1227/NEU.0B013E31824D179B |
P698 | PubMed publication ID | 22307074 |
P50 | author | Geoffrey T. Manley | Q111306825 |
P2093 | author name string | Michael C Huang | |
Mitchell Jay Cohen | |||
Matthew E Kutcher | |||
Mathieu Laroche | |||
P2860 | cites work | Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial | Q28285511 |
The risk associated with aprotinin in cardiac surgery | Q28293732 | ||
Antithrombin treatment in patients with traumatic brain injury: a pilot study. | Q31806172 | ||
Antifibrinolytic therapy use to mitigate blood loss during staged complex major spine surgery: Postoperative visual color changes after tranexamic acid administration | Q33272721 | ||
Coagulation abnormalities associated with severe isolated traumatic brain injury: cerebral arterio-venous differences in coagulation and inflammatory markers | Q33374049 | ||
Platelet dysfunction in patients with severe traumatic brain injury | Q33377367 | ||
Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa. | Q33377855 | ||
Early coagulopathy after isolated severe traumatic brain injury: relationship with hypoperfusion challenged | Q33389206 | ||
Time course of coagulopathy in isolated severe traumatic brain injury | Q33389565 | ||
Defibrination after brain-tissue destruction: A serious complication of head injury | Q33466827 | ||
Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis | Q34113316 | ||
Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction | Q34350327 | ||
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology | Q34946830 | ||
Coagulation abnormalities in the trauma patient: the role of point-of-care thromboelastography | Q35204283 | ||
Differentiation of enzymatic from platelet hypercoagulability using the novel thrombelastography parameter delta (delta) | Q35216730 | ||
Delayed brain injury after head trauma: significance of coagulopathy | Q35905754 | ||
Thrombelastography/thromboelastometry. | Q36077355 | ||
Coagulopathy in traumatic brain injury | Q36262718 | ||
Platelet aggregability in relation to impaired consciousness after head injury | Q36593368 | ||
Increase in activated protein C mediates acute traumatic coagulopathy in mice | Q36615864 | ||
The use of recombinant factor VIIa (NovoSeven) for treatment of active or impending bleeding in brain injury: broadening the indications. | Q36663711 | ||
Acute coagulopathy of trauma: mechanism, identification and effect | Q36987852 | ||
Hemostatic abnormalities in patients with closed head injuries and their role in predicting early mortality | Q48479217 | ||
Clinicopathological correlations of disseminated intravascular coagulation in patients with head injury | Q48650642 | ||
Transcranial cytokine gradients in patients requiring intensive care after acute brain injury | Q48715360 | ||
Change in tissue thromboplastin content of brain following trauma | Q48810222 | ||
Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM). | Q50700389 | ||
The efficacy and safety of aprotinin for hemostasis during intracranial surgery. | Q51294864 | ||
Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. | Q53223726 | ||
Treatment of traumatic bleeding with recombinant factor VIIa. | Q55033461 | ||
Point-of-care platelet function testing | Q37083098 | ||
Methods to evaluate the pharmacology of oral antiplatelet drugs | Q37200613 | ||
Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator | Q37263891 | ||
The surgical application of point-of-care haemostasis and platelet function testing | Q37290009 | ||
Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature | Q37395520 | ||
Erythrocyte-bound tissue plasminogen activator is neuroprotective in experimental traumatic brain injury | Q37397703 | ||
Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography | Q37707866 | ||
Thromboelastographic study of biomaterials. | Q37768388 | ||
Treatment of coagulopathy in intracranial hemorrhage | Q37788997 | ||
The prognostic value of thrombelastography in identifying neurosurgical patients with worse prognosis. | Q37862024 | ||
Disseminated intravascular coagulation and head injury | Q39292359 | ||
Acute coagulopathy in isolated blunt traumatic brain injury | Q39941373 | ||
Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study | Q40231512 | ||
Coagulopathy in acute head injury--a study of its role as a prognostic indicator | Q40869167 | ||
Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody | Q41209908 | ||
Hyperfibrinolysis during intracranial surgery: effect of high dose aprotinin | Q41888918 | ||
Slippery platelet syndromes in subdural hematoma | Q43164303 | ||
Infusion of prostacyclin following experimental brain injury in the rat reduces cortical lesion volume. | Q43563613 | ||
Extracranial complications of severe head injury | Q43673487 | ||
Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury | Q43856783 | ||
Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. | Q43867973 | ||
Early fresh frozen plasma prophylaxis of abnormal coagulation parameters in the severely head-injured patient is not effective | Q43902441 | ||
Aprotinin and deep hypothermic cardiopulmonary bypass with or without circulatory arrest for craniotomy | Q43926331 | ||
Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury | Q44467529 | ||
Disseminated intravascular coagulation and head trauma. Two case studies | Q44529770 | ||
Disseminated intravascular coagulation associated with massive brain injury | Q44545125 | ||
Disturbances of the coagulatory system in patients with severe cerebral trauma. I | Q44954754 | ||
Delayed thrombosis after traumatic brain injury in rats | Q45246841 | ||
Traumatic coagulopathy: the effect of brain injury. | Q46021494 | ||
The impact of platelets on the progression of traumatic intracranial hemorrhage | Q46235532 | ||
Experimental fluid percussion brain injury: vascular disruption and neuronal and glial alterations | Q46383979 | ||
Platelet activation and function after trauma | Q46796249 | ||
Rapid administration of antifibrinolytics and strict blood pressure control for intracerebral hemorrhage | Q46801346 | ||
Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats | Q48113684 | ||
Disturbances of the coagulatory system in patients with severe cerebral trauma II | Q48119623 | ||
Head injury and coagulation disorders | Q48164283 | ||
Correlation of admission fibrin degradation products with outcome and respiratory failure in patients with severe head injury | Q48196632 | ||
Brain tumors and thromboembolic complications | Q48225141 | ||
Relationship between abnormalities of coagulation and fibrinolysis and postoperative intracranial hemorrhage in head injury | Q48290670 | ||
Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients | Q48308021 | ||
The effect of fresh frozen plasma in severe closed head injury. | Q48400782 | ||
Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage | Q48412367 | ||
Intravascular coagulation: a major secondary insult in nonfatal traumatic brain injury | Q48416467 | ||
Clotting onset time may be a predictor of outcome in human brain injury: a pilot study | Q48419851 | ||
Perioperative assessment of coagulation in paediatric neurosurgical patients using thromboelastography | Q48433782 | ||
Temporal profile of thrombogenesis in the cerebral microcirculation after traumatic brain injury in mice | Q48442670 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | blood coagulation disease | Q890200 |
traumatic brain injury | Q1995526 | ||
P304 | page(s) | 1334-1345 | |
P577 | publication date | 2012-06-01 | |
P1433 | published in | Neurosurgery | Q7002693 |
P1476 | title | Coagulopathy after traumatic brain injury | |
P478 | volume | 70 |
Q38242952 | Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: Definition, incidence and outcomes. |
Q36902530 | Antiplatelet therapy: a double-edged sword in head injury? |
Q35146718 | Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury. |
Q47866858 | Blood ethanol levels are not related to coagulation changes, as measured by thromboelastography, in traumatic brain injury patients |
Q38879831 | Characterization of distinct coagulopathic phenotypes in injury: Pathway-specific drivers and implications for individualized treatment |
Q38191128 | Coagulopathy after severe pediatric trauma |
Q38072761 | Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options |
Q39443587 | Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management |
Q38138903 | Coagulopathy associated with traumatic brain injury |
Q90381038 | Effect of Hypernatremia on Outcomes After severe Traumatic Brain Injury: A Nationwide Inpatient Sample analysis |
Q38703268 | Epidural Hematoma Treated Conservatively: When to Expect the Worst. |
Q44633047 | External validation of the international mission for prognosis and analysis of clinical trials model and the role of markers of coagulation. |
Q41851466 | Factors related to catheter-induced hemorrhage after brain parenchymal catheterization |
Q60958912 | Hypertonic saline maintains coagulofibrinolytic homeostasis following moderate‑to‑severe traumatic brain injury by regulating monocyte phenotype via expression of lncRNAs |
Q37272702 | Impact of moderate blast exposures on thrombin biomarkers assessed by calibrated automated thrombography in rats |
Q37724445 | Increased Risk of Stroke in Patients of Concussion: A Nationwide Cohort Study |
Q26750920 | Management of Deep Vein Thrombosis (DVT) Prophylaxis in Trauma Patients |
Q48244928 | Microparticles impact coagulation after traumatic brain injury. |
Q99630789 | Modern Management of Bleeding, Clotting, and Coagulopathy in Trauma Patients: What Is the Role of Viscoelastic Assays? |
Q30352890 | NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface. |
Q26768672 | New Prognostic Biomarkers in Patients With Traumatic Brain Injury |
Q101138973 | Outcome prediction of TBI - Are there parameters that affect the IMPACT and CRASH models? |
Q47322914 | Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy. |
Q38126028 | Prevention of venous thrombotic events in brain injury: review of current practices |
Q47179267 | Prognostic value of coagulation tests for in-hospital mortality in patients with traumatic brain injury. |
Q39109184 | Progressive hemorrhagic injury in patients with traumatic intracerebral hemorrhage: characteristics, risk factors and impact on management. |
Q39221209 | Response of the cerebral vasculature following traumatic brain injury |
Q48605563 | Retrospective evaluation of the BIG score to predict mortality in pediatric blunt trauma |
Q38567028 | Review of Thromboelastography in Neurocritical Care. |
Q92158321 | Risk Factors for Venous Thromboembolism After Admission for Traumatic Subdural Hematoma at Level I Trauma Center: Large Single-Institution Series |
Q26995130 | Role of fibrinogen in cerebrovascular dysfunction after traumatic brain injury |
Q41288406 | Side Effects of Indomethacin in Refractory Post-traumatic Intracranial Hypertension: A comprehensive case study and review |
Q91868654 | Systemic Immune Response to Traumatic CNS Injuries-Are Extracellular Vesicles the Missing Link? |
Q42908897 | Systemic platelet dysfunction is the result of local dysregulated coagulation and platelet activation in the brain in a rat model of isolated traumatic brain injury |
Q37731832 | Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy |
Q48116820 | The Utility of Thromboelastography for Predicting The Risk of Progression of Intracranial Hemorrhage in Traumatic Brain Injury Patients. |
Q53060218 | The coagulopathy of trauma. |
Q49151889 | Thromboelastography After Murine TBI and Implications of Beta-Adrenergic Receptor Knockout |
Q43723087 | Thromboelastography defines late hypercoagulability after TBI: a pilot study |
Q38978286 | Timing of fracture fixation from an Intensive Care Unit perspective: the obstacles to early fracture fixation |
Q33786832 | Traumatic brain injury causes platelet adenosine diphosphate and arachidonic acid receptor inhibition independent of hemorrhagic shock in humans and rats. |
Q38774838 | Tripartite Stratification of the Glasgow Coma Scale in Children with Severe Traumatic Brain Injury and Mortality: An Analysis from a Multi-Center Comparative Effectiveness Study |
Q42777722 | What's new in emergencies, trauma, and shock? Heparin in severe traumatic brain injury: Beyond venous thromboembolism prevention? |
Q38238825 | Where are we in the modelling of traumatic brain injury? Models complicated by secondary brain insults |
Search more.